Raadi | Blue Cross MN

Soo bandhiga 2271 - 2280 ee natiijooyinka 3289

Bixiye

P35-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers

Wax badan akhri

Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2021

Bixiye

P33-21 Change to Medical Review Process for Outpatient Therapies Services

Wax badan akhri

Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2021

Bixiye

QP45-21 Medical Drug Update for Botulinum Toxins (Myobloc, Botox, Dysport, Xeomin) - Commercial Products

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: May 26, 2021

Bixiye

QP46-21 Incorrect ID Cards Issued for Minnesota Health Care Programs Members

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: May 26, 2021

Bixiye

QP43-21 MHCP Pharmacy Benefit Exclusion for Jemperli and Zynlonta™

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: May 26, 2021

Bixiye

QP44-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Zeposia® (ozanimod)

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: May 26, 2021

Bixiye

2021 June Provider Press

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2021

Bixiye

QP41-21 Commercial and MHCP Pharmacy Benefit Exclusion for Qutenza®

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: May 12, 2021

Bixiye

QP40-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective July 1, 2021

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: May 12, 2021

Bixiye

QP42-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Agents

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: May 12, 2021